###
中国临床研究:2026,39(10):1563-1566
本文二维码信息
码上扫一扫!
NLR、MLR和CAR对克罗恩病乌司奴单抗治疗效果的预测价值
(1. 皖南医科大学第一附属医院(弋矶山医院)消化内科,安徽 芜湖 241001;2. 皖南医科大学第一附属医院(弋矶山医院)关节骨科,安徽 芜湖 241001)
Predictive value of NLR,MLR and CAR on the efficacy of ustekinumab in patients with Crohn's disease
摘要
本文已被:浏览 223次   下载 116次
投稿时间:2026-05-08   网络发布日期:2026-10-23
中文摘要: 目的  检测接受乌司奴单抗治疗的克罗恩病患者中性粒细胞与淋巴细胞比值(NLR)、单核细胞与淋巴细胞比值(MLR)、C反应蛋白与白蛋白比值(CAR),探讨此三项指标及其联合对乌司奴单抗治疗克罗恩病患者疗效的预测价值。方法  回顾性分析皖南医科大学弋矶山医院2021年1月至2025年12月收治的61例克罗恩病患者的临床资料,所有患者均行乌司奴单抗治疗。根据治疗效果,将失应答的18例患者纳入A组,将治疗有效的43 例患者纳入B 组。观察两组患者NLR、MLR、CAR,绘制受试者工作特征(ROC)曲线评价NLR、MLR、CAR对克罗恩病患者乌司奴单抗治疗效果的预测价值。结果  A 组的NLR(2.74±1.43 vs 1.79±0.71,t=2.683,P=0.014)、MLR(0.30±0.11 vs 0.23±0.06,t=2.546,P=0.016)和CAR[0.31(0.14,0.51)vs 0.05(0.03,0.08),Z=5.134,P<0.01]显著高于B组。ROC曲线分析显示,NLR、MLR、CAR预测克罗恩病患者乌司奴单抗治疗失应答的ROC曲线下面积(AUC)分别为0.756、0.753、0.918,上述指标联合预测的AUC为0.970。结论  NLR、MLR、CAR对克罗恩病患者乌司奴单抗治疗应答均有一定预测价值,联合预测效能最高,有助于早期识别乌司奴单抗治疗失应答患者。
Abstract:Objective To investigate the levels of neutrophil-to-lymphocyte ratio(NLR),monocyte-to-lymphocyte ratio(MLR),and C-reactive protein-to-albumin ratio(CAR)in patients with Crohn's disease treated with ustekinumab,and to evaluate the predictive value of these three individual indicators and their combination for the efficacy of ustekinumab in the treatment of Crohn's disease patients. Methods A retrospective analysis was performed on medical records of 61 patients with Crohn's disease who were treated with ustekinumab at Yijishan Hospital of Wannan Medical University from January 2021 to December 2025. Based on treatment outcomes,18 patients with loss of response were assigned to group A,and 43 patients with effective response were assigned to group B. NLR,MLR,and CAR were compared between the two groups. Receiver operating characteristic(ROC)curves were constructed to assess the predictive value of NLR,MLR,CAR,and their combination for the efficacy of ustekinumab therapy. Results NLR(2.74±1.43 vs 1.79±0.71,t=2.683,P=0.014),MLR(0.30±0.11 vs 0.23±0.06,t=2.546,P=0.016),and CAR[0.31(0.14,0.51)vs 0.05(0.03,0.08),Z=5.134,P<0.01]in group A were significantly higher than those in group B. ROC curve analysis showed that the area under the curve (AUC)for NLR,MLR,and CAR alone in predicting loss of response to ustekinumab were 0.756,0.753,and 0.918,respectively,while the AUC for the combined indicators was 0.970.Conclusion NLR,MLR,and CAR each has certain predictive value for the therapeutic efficacy of ustekinumab in patients with Crohn's disease. The combination of these indicators yields the highest predictive performance and may facilitate early identification of patients with loss of response to ustekinumab therapy.
文章编号:     中图分类号:R574    文献标志码:A
基金项目:安徽省临床医学研究转化专项项目(202527c10020096,202427b1002007);皖南医科大学第一附属医院管理与服务创新项目(CX2025035)
附件
引用文本:
王晶,李琳,陈平波,等.NLR、MLR和CAR对克罗恩病乌司奴单抗治疗效果的预测价值[J].中国临床研究,2026,39(10):1563-1566.

用微信扫一扫

用微信扫一扫